Grabbert M, Seiler R, Gratzke C. Re: Intravesical Nadofaragene Firadenovec Gene Therapy for BCG-unresponsive Non-muscle-invasive Bladder Cancer: A Single-arm, Open-label, Repeat-dose Clinical Trial Boorjian SA, Alemozaffar M, Konety BR, et al Lancet Oncol 2021;22:107-17. Eur Urol 2021 Feb 20. pii: S0302-2838(21)00099.
PMID: 33622578